Biotech ETFs Could Use Some Mergers & Acquisitions
This article was originally published on ETFTrends.com.
The VanEck Vectors Biotech ETF (NYSEArca: BBH) is up nearly 8% year-to-date, but some industry observers are speculating that for large-cap biotechnology stocks to rally again, some more mergers and acquisitions activity will be required. BBH holds 25 stocks and tracks the MVIS US Listed Biotech 25 Index, “which is intended to track the overall [...]